Skip to main content

Table 4 Unadjusted and adjusted models for predictors of mortality across 33 MSF sites providing ART care

From: Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries

Model outcome

Level

Mortality

Mortality with lost to follow-up as a competing risk

Predictor

Adjusted hazard ratio (95 % CI)

p value

Adjusted hazard ratio (95 % CI)

p value

Treatment interruption

 

0.21 (0.18, 0.23)

<0.01

0.95 (0.89, 1.02)

0.18

WHO stage at ART initiation

1

Ref.

 

Ref.

 

2

1.06 (0.81, 1.40)

0.67

1.06 (0.80, 1.40)

0.68

3

2.41 (1.95, 2.98)

<0.01

2.50 (2.02, 3.09)

<0.01

4

4.31 (3.48, 5.33)

<0.01

4.50 (3.64, 5.56)

<0.01

CD4 count at ART initiation (cells/μL)

<200

Ref.

 

Ref.

 

200–350

0.55 (0.48, 0.64)

<0.01

0.54 (0.47, 0.62)

<0.01

>350

0.41 (0.30, 0.55)

<0.01

0.40 (0.29, 0.53)

<0.01